These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 15941732)

  • 1. Antiretroviral therapy in resource-poor settings: scaling up inequalities?
    Egger M; Boulle A; Schechter M; Miotti P
    Int J Epidemiol; 2005 Jun; 34(3):509-12. PubMed ID: 15941732
    [No Abstract]   [Full Text] [Related]  

  • 2. The obligation to provide antiretroviral treatment in HIV prevention trials.
    Lo B; Padian N; Barnes M
    AIDS; 2007 Jun; 21(10):1229-31. PubMed ID: 17545698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Access to antiretroviral treatment in developing countries: Which financing strategies are possible?
    Beaulière A; Le Maux A; Trehin C; Perez F
    Rev Epidemiol Sante Publique; 2010 Jun; 58(3):171-9. PubMed ID: 20430553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up.
    Calmy A; Klement E; Teck R; Berman D; Pécoul B; Ferradini L
    AIDS; 2004 Dec; 18(18):2353-60. PubMed ID: 15622311
    [No Abstract]   [Full Text] [Related]  

  • 5. COMMENTARY: understanding the benefits of pediatric anti-retroviral treatment in resource-limited settings.
    Hetherington S
    Pediatr Infect Dis J; 2009 Jan; 28(1):41-2. PubMed ID: 19057455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The marriage of science and optimized HIV care in resource-limited settings.
    Calmy A; Pizzocolo C; Pizarro L; Brücker G; Murphy R; Katlama C;
    AIDS; 2008 Nov; 22(17):2227-30. PubMed ID: 18981761
    [No Abstract]   [Full Text] [Related]  

  • 7. Strategies for the scale-up of antiretroviral therapy in South Africa through health system optimization.
    Barker PM; McCannon CJ; Mehta N; Green C; Youngleson MS; Yarrow J; Bennett B; Berwick DM
    J Infect Dis; 2007 Dec; 196 Suppl 3():S457-63. PubMed ID: 18181694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The challenges to scaling up antiretroviral therapy in Papua New Guinea.
    Raynes P; Maibani G
    P N G Med J; 2006; 49(1-2):32-42. PubMed ID: 18396610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scaling-up antiretroviral treatment in resource-poor countries: prioritization and choices.
    Korenromp EL; Fakoya A; Viisainen K
    AIDS; 2011 Mar; 25(6):857-9. PubMed ID: 21412061
    [No Abstract]   [Full Text] [Related]  

  • 10. AIDS. Resource needs for HIV/AIDS.
    Schwartländer B; Stover J; Walker N; Bollinger L; Gutierrez JP; McGreevey W; Opuni M; Forsythe S; Kumaranayake L; Watts C; Bertozzi S
    Science; 2001 Jun; 292(5526):2434-6. PubMed ID: 11423619
    [No Abstract]   [Full Text] [Related]  

  • 11. Introduction: the realities of antiretroviral therapy rollout: overcoming challenges to successful programmatic implementation.
    Ojikutu B
    J Infect Dis; 2007 Dec; 196 Suppl 3():S445-8. PubMed ID: 18181692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationing antiretroviral therapy for HIV/AIDS in Africa: choices and consequences.
    Rosen S; Sanne I; Collier A; Simon JL
    PLoS Med; 2005 Nov; 2(11):e303. PubMed ID: 16159308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scaling up treatment--why we can't wait.
    Kim JY; Gilks C
    N Engl J Med; 2005 Dec; 353(22):2392-4. PubMed ID: 16319389
    [No Abstract]   [Full Text] [Related]  

  • 14. Ethical and programmatic challenges in antiretroviral scaling-up in Malawi: challenges in meeting the World Health Organization's "Treating 3 million by 2005" initiative goals.
    Muula AS
    Croat Med J; 2004 Aug; 45(4):415-21. PubMed ID: 15311413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to TB preventive therapy for HIV-positive patients in rural South Africa: implications for antiretroviral delivery in resource-poor settings?
    Rowe KA; Makhubele B; Hargreaves JR; Porter JD; Hausler HP; Pronyk PM
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):263-9. PubMed ID: 15786888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral therapy-associated toxicities in the resource-poor world: the challenge of a limited formulary.
    Murphy RA; Sunpath H; Kuritzkes DR; Venter F; Gandhi RT
    J Infect Dis; 2007 Dec; 196 Suppl 3():S449-56. PubMed ID: 18181693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suitable monitoring approaches to antiretroviral therapy in resource-poor settings: setting the research agenda.
    Kent DM; McGrath D; Ioannidis JP; Bennish ML
    Clin Infect Dis; 2003 Jul; 37(Suppl 1):S13-24. PubMed ID: 12822128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2007 costs and coverage of antiretrovirals under Medicare Part D for people with HIV/AIDS living in North Carolina.
    Sengupta S
    N C Med J; 2008; 69(1):6-13. PubMed ID: 18429558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prioritizing antiretrovirals for second-line therapy in resource-limited countries.
    Naidoo K
    AIDS Clin Care; 2008 May; 20(5):43. PubMed ID: 19230296
    [No Abstract]   [Full Text] [Related]  

  • 20. [HIV antiretroviral agents: new threats to accessibility in developing countries].
    Nau JY
    Rev Med Suisse; 2005 Dec; 1(45):2956. PubMed ID: 16425957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.